SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-118493
Filing Date
2011-04-29
Accepted
2011-04-29 16:04:07
Documents
2
Period of Report
2011-06-01
Effectiveness Date
2011-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 587993
2 GRAPHIC g163086g37n39.jpg GRAPHIC 17244
  Complete submission text file 0001193125-11-118493.txt   612977
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 11794651
SIC: 2834 Pharmaceutical Preparations